JP Morgan Chase
CELU icon

JP Morgan Chase’s Celularity CELU Stock Holding History

JP Morgan Chase’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20 Hold
16
– – ﹤0.01% 7409
2025
Q4 		$18 Hold
16
– – ﹤0.01% 7310
2025
Q3 		$33 Hold
16
– – ﹤0.01% 7255
2025
Q2 		$31 Sell
16
-27
-63% -$49 ﹤0.01% 6930
2025
Q1 		$75 Hold
43
– – ﹤0.01% 6913
2024
Q4 		$89 Buy
43
+27
+169% +$64 ﹤0.01% 7022
2024
Q3 		$48 Hold
16
– – ﹤0.01% 7127
2024
Q2 		$50 Hold
16
– – ﹤0.01% 7028
2024
Q1 		$84 Hold
16
– – ﹤0.01% 6937
2023
Q4 		$40 Hold
16
– – ﹤0.01% 7234
2023
Q3 		$36 Hold
16
– – ﹤0.01% 7046
2023
Q2 		$86 Sell
16
-4,863
-100% -$31.2K ﹤0.01% 6708
2023
Q1 		$30K Buy
4,879
+1,257
+35% +$10.1K ﹤0.01% 5866
2022
Q4 		$46K Sell
3,622
-42
-1% -$774 ﹤0.01% 5647
2022
Q3 		$84K Buy
3,664
+2,819
+334% +$85.5K ﹤0.01% 5362
2022
Q2 		$28K Buy
+845
New +$68.6K ﹤0.01% 5813
2021
Q2 		– Sell
-115,977
Closed -$11.7M – 6366
2021
Q1 		$11.7M Buy
115,977
+78,424
+209% +$8.04M ﹤0.01% 2217
2020
Q4 		$4.13M Sell
37,553
-2,026
-5% -$215K ﹤0.01% 2971
2020
Q3 		$4.12M Buy
+39,579
New +$4.1M ﹤0.01% 2724

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

JP Morgan Chase's CELU Position: Q1 2026 in Review

JP Morgan Chase held its Celularity (CELU) position steady in Q1 2026 at 16 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #7409.

JP Morgan Chase first reported a position in CELU in Q3 2020 and has held it in 19 quarters since. The position peaked at $11.7M in Q1 2021. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • JP Morgan Chase held 16 shares of Celularity worth $20 as of Q1 2026.
  • JP Morgan Chase left its Celularity share count unchanged in Q1 2026.
  • Celularity made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7409 holding.
  • JP Morgan Chase first reported a position in Celularity in Q3 2020 and has held it in 19 quarters since.
  • JP Morgan Chase's Celularity position peaked at $11.7M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.